Forbes contributors publish independent expert analyses and insights. James Broughel is an economist focused on the economics of regulation. Shortages are most damaging when they involve basic ...

The House of Representatives just passed a resolution condemning the “horrors of socialism” by a 285 to 98 margin. All the no votes were cast by Democrats indicating that a majority of the members ...

The Trump administration recently released an executive order directing Medicare and Medicaid drug reimbursement to be based on prices in other countries, using a model called Most Favored Nation (MFN ...

Approximately 3.2 million Americans suffering from cancer, heart disease, and other serious or life-threatening diseases benefit from home infusion therapy. As the name suggests, home infusion therapy ...

For decades, America’s drug-price debate has centered on a fundamental tension: How do policymakers encourage expensive research and development, while ensuring that companies keep final prices ...

The Colorado House has advanced a bill to bar companies from using personal data to set individualized wages and prices. As The Gazette reports, House Bill 26-1210 is a reincarnated version of a ...

The author argues that North Carolina's economic success is due to policies that encourage private-sector growth and innovation. Government-imposed price controls, particularly on prescription ...

Ever since college, I have subscribed to the Enlightenment view of the world, which is based on the belief that knowledge mostly moves forward. Experimentation and scholarship produce facts and ...

Price controls introduced at German petrol stations to shield motorists from spiking oil prices amid the Middle East war have had the opposite effect and driven up the average cost of fuel, economists ...

Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 a month. Patients buying directly from the manufacturer will be able to pay ...

Remember when Republican presidential candidate Donald Trump castigated “Comrade Kamala” Harris, then the Democratic nominee, for supporting price controls? It wasn’t that long ago — just last August.